{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:55:13Z","timestamp":1648770913927},"reference-count":43,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.lpm.2015.02.020","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T04:02:09Z","timestamp":1434168129000},"page":"716-726","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic et prise en charge clinique des infections cervicales \u00e0 HPV"],"prefix":"10.1016","volume":"44","author":[{"given":"Xavier","family":"Carcopino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Camus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Halfon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2015.02.020_bib0220","series-title":"Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980\u00a0et 2012. Partie 1 \u2013 Tumeurs solides","first-page":"122","author":"Binder-Foucard","year":"2013"},{"key":"10.1016\/j.lpm.2015.02.020_bib0225","series-title":"Projection de l\u2019incidence et de la mortalit\u00e9 par cancer en France en 2011. Rapport technique","author":"INVS","year":"2011"},{"key":"10.1016\/j.lpm.2015.02.020_bib0230","series-title":"\u00c9tat des lieux et recommandations pour le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus en France. Synth\u00e8se et Recommandations","author":"HAS","year":"2010"},{"key":"10.1016\/j.lpm.2015.02.020_bib0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.lpm.2015.02.020_bib0240","series-title":"Recommandations pour la pratique clinique\u00a0: pr\u00e9vention du cancer du col de l\u2019ut\u00e9rus. Mises \u00e0 jour de gyn\u00e9cologie m\u00e9dicale","first-page":"527","author":"CNGOF","year":"2007"},{"key":"10.1016\/j.lpm.2015.02.020_bib0245","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.gyobfe.2007.07.019","article-title":"Cytological history of cases of invasive cervical cancer diagnosed in France in 2006","volume":"35","author":"Boulanger","year":"2007","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.lpm.2015.02.020_bib0250","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1051\/medsci\/20132912021","article-title":"Age for HPV vaccination: recommendations from the French high council of public health","volume":"29","author":"Heard","year":"2013","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.lpm.2015.02.020_bib0255","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.02.020_bib0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6","article-title":"Human papillomavirus \u2013 the most significant risk determinant of cervical intraepithelial neoplasia","volume":"65","author":"Kjaer","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquisition associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2015.02.020_bib0270","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.02.020_bib0275","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","article-title":"Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia","volume":"286","author":"Schlecht","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2015.02.020_bib0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2","article-title":"Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types","volume":"87","author":"Jacobs","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0285","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.02.020_bib0290","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"De Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lpm.2015.02.020_bib0295","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/0008-5472.CAN-07-2754","article-title":"Type-dependent integration frequency of human papillomavirus genomes in cervical lesions","volume":"68","author":"Vinokurova","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.lpm.2015.02.020_bib0300","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.23092","article-title":"Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0305","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ijc.23093","article-title":"Human papillomavirus genotype distribution in high-grade cervical lesions (CIN 2\/3) in France: EDITH study","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2008.04.012","article-title":"Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2\/3 and invasive cervical cancer: the EDiTH III study","volume":"110","author":"Pretet","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lpm.2015.02.020_bib0315","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1086\/590560","article-title":"Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV)","volume":"47","author":"Aubin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2015.02.020_bib0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2009.06.016","article-title":"Natural history of persistent high-risk human papillomavirus infections in Korean women","volume":"115","author":"Bae","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lpm.2015.02.020_bib0325","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lpm.2015.02.020_bib0330","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ijc.22677","article-title":"Risk of high-grade cervical intraepithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months","volume":"121","author":"Bulk","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0335","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.lpm.2015.02.020_bib0340","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/ijc.23339","article-title":"Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology \u2013 results from the Hammersmith study","volume":"122","author":"Cuzick","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0345","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.02.020_bib0350","series-title":"Conduite \u00e0 tenir devant une patiente ayant un frottis cervico-ut\u00e9rin anormal. Actualisation 2002","author":"ANAES","year":"2002"},{"issue":"Suppl. 5","key":"10.1016\/j.lpm.2015.02.020_bib0355","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"9916","key":"10.1016\/j.lpm.2015.02.020_bib0360","first-page":"524","article-title":"DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials","volume":"383","author":"Pileggi","year":"2013","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.lpm.2015.02.020_bib0365","first-page":"481","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"117","author":"Ronco","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.02.020_bib0370","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2010.01.037","article-title":"What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?","volume":"117","author":"Huh","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.lpm.2015.02.020_bib0375","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","article-title":"The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period","volume":"66","author":"Kjaer","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.lpm.2015.02.020_bib0380","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.bjc.6601726","article-title":"Negative human papillomavirus testing in normal smears selects a population at low-risk for developing high-grade cervical lesions","volume":"90","author":"Clavel","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0385","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/sj.bjc.6602541","article-title":"Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening","volume":"92","author":"Bulkmans","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lpm.2015.02.020_bib0390","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"Future II Study Group","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2015.02.020_bib0395","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2015.02.020_bib0400","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jgyn.2013.03.013","article-title":"The follow-up of the women vaccinated against HPV","volume":"42","author":"Riethmuller","year":"2013","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.lpm.2015.02.020_bib0405","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.vaccine.2011.02.064","article-title":"HPV vaccination in France: uptake, costs and issues for the National Health Insurance","volume":"29","author":"Fagot","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lpm.2015.02.020_bib0410","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgyn.2011.10.001","article-title":"HPV prophylactic vaccine coverage in France: results of a survey among high school and university students in Marseilles\u2019 area","volume":"41","author":"Sabiani","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.020_bib0415","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jgyn.2014.02.005","article-title":"HPV prophylactic vaccine coverage and factors impacting its practice among students and high school students in Marseilles\u2019 area","volume":"44","author":"Baudoin","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.lpm.2015.02.020_bib0420","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long-term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2015.02.020_bib0425","series-title":"Conditions pr\u00e9-analytiques de r\u00e9alisation de la recherche du g\u00e9nome (ADN) des Papillomavirus humains (HPV) oncog\u00e8nes \u00e0 partir de frottis cervico-ut\u00e9rins","author":"HAS","year":"2013"},{"issue":"2","key":"10.1016\/j.lpm.2015.02.020_bib0215","first-page":"213","article-title":"Cytological and virological medium performance and stability assessment using the Cobas 4800 HPV test (Roche) used in France","volume":"72","author":"Khiri","year":"2014","journal-title":"Ann Biol Clin"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215002626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498215002626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T21:47:01Z","timestamp":1566856021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498215002626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":43,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0755498215002626"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2015.02.020","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic et prise en charge clinique des infections cervicales \u00e0 HPV","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2015.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}